We will begin this segment with a look back at a story that caused public panic. One of the nation's leading vaccine makers, Changchun Changsheng, was found to have manufactured substandard vaccines, and falsified its production records. China's legislature is now reviewing a draft law on vaccine management. CGTN's Xu Mengqi recaps the scandal and the fall-out.

"They're vaccines for kids! This is very very infuriating."

XU MENGQI BEIJING "Rabies can often be fatal, and people have high expectations for vaccines that treat it. When news broke on July 15, that Changchun Changsheng, China's second largest rabies vaccine manufacturer, faked its production records, it quickly caught public attention. And just four days later, the company was fined for another batch of substandard vaccines for infants and young children."

"If anything ever were to happen to our child, how would we go on?"

Even though the mothers shied away from the camera, they did not hide their anger. There was public outcry.

DR. BABAK JAVID, PROFESSOR TSINGHUA UNIVERSITY SCHOOL OF MEDICINE "Because vaccines prevent rather than treat diseases, safety has to be the number one consideration. China has been historically fantastic at having excellent coverage and my concern is that there is a further erosion of public trust and coverage decreases, that's gonna have a significant public health impact."

After the scandal broke, Changchun Changsheng was fined 1.3 billion USD, 16 times its net profit in 2017. The company's good manufacturing practice (GMP) certificate was revoked, and its executives arrested.

Now China's top legislature is deliberating a draft law on vaccine management, which specifies severe punishment for future violators.

"It's not the first time China's had a major vaccine scandal. In fact, we've had a few in the past decade. But it is the first time China has made a separate law on vaccine management. Do you think new legislation will help prevent future scandals?"

DR. BABAK JAVID, PROFESSOR TSINGHUA UNIVERSITY SCHOOL OF MEDICINE "So I think the legislation certainly is important as to be welcomed, but if we look at historically industrialized nations such as in the west, legislation has always worked in collaboration with other factors. Most pharmaceutical companies have got decades-long heritage in making medicines for the public and therefore they learned to practice self-discipline and put public safety first, rather than motivated by profits."

XU MENGQI BEIJING "The draft legislation makes it clear that vaccinations are for the good of the public, and there will be stricter regulations regarding licensing, production, and even circulation and distribution. For companies in the vaccine industry, this could be a game-changer. But for the general public, this might be what they need to restore their trust in vaccinations. XMQ, CGTN, BJ.